70 related articles for article (PubMed ID: 24245795)
1. PAX immunoreactivity patterns in anaplastic wilms tumors.
Fan R
Fetal Pediatr Pathol; 2014 Feb; 33(1):60-3. PubMed ID: 24245795
[TBL] [Abstract][Full Text] [Related]
2. p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.
Huang J; Soffer SZ; Kim ES; Yokoi A; Moore JT; McCrudden KW; Manley C; Middlesworth W; O'Toole K; Stolar C; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2002 Mar; 37(3):523-7. PubMed ID: 11877681
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of neural cell adhesion molecule in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices.
Kapur P; Rakheja D
Pediatr Dev Pathol; 2011; 14(1):16-9. PubMed ID: 20524836
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
Rakheja D; Khokhar S; Mitui M; Cost NG
Pediatr Dev Pathol; 2012; 15(4):286-92. PubMed ID: 22483234
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
7. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
8. Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor.
Tamimi Y; Dietrich K; Stone K; Grundy P
Mutat Res; 2006 Oct; 601(1-2):46-50. PubMed ID: 16814811
[TBL] [Abstract][Full Text] [Related]
9. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
10. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
11. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
12. p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness.
Franken J; Lerut E; Van Poppel H; Bogaert G
J Urol; 2013 Feb; 189(2):664-70. PubMed ID: 23036984
[TBL] [Abstract][Full Text] [Related]
13. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children.
Shao L; Hill DA; Perlman EJ
Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525
[TBL] [Abstract][Full Text] [Related]
14. Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 May; 19(3):140-51. PubMed ID: 22498579
[TBL] [Abstract][Full Text] [Related]
15. Adult Wilms' tumour. A case report with immunohistochemical studies.
Sápi Z; Svastics E
Acta Morphol Hung; 1990; 38(1):55-60. PubMed ID: 1708644
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
Ellison DA; Parham DM; Bridge J; Beckwith JB
Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry.
Scursoni AM; Galluzzo L; Camarero S; Pozzo N; Gabri MR; de Acosta CM; Vázquez AM; Alonso DF; de Dávila MT
Pediatr Dev Pathol; 2010; 13(1):18-23. PubMed ID: 19435393
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
20. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
